Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine Switching in Acute Mania
NCT00837343Phase 4Unknown
- Sponsor
- The Affiliated Brain Hospital of Guangzhou Medical University
- Start
- Dec 2008
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of quetiapine (extended-release tablet, brand name: Bipresso) in bipolar disorder (BD), sponsored by The Affiliated Brain Hospital of Guangzhou Medical University. Primary endpoint: Young Mania Rating Scale Total Score Change at 28 days. Status: unknown.
02
Drugs
quetiapine (extended-release tablet, brand name: Bipresso)
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00837343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00837343.